Therapeutic Market Prospects for Human Papillomavirus (HPV), 2019-2023, with Allergan, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings and Merck Sharp & Dominant Dohme – ResearchAndMarkets.com

DUBLIN – (BUSINESS WIRE)–The "Global
Human Papillomavirus (HPV) Therapeutics Market 2019-2023 "
the report was added to ResearchAndMarkets.com & # 39; s
offer.

Human papillomavirus (HPV) treatment market will register a PCAR
by almost 9% by 2023.

Technological advances in diagnosis to stimulate market growth

Diagnostic methods currently available on the market
include Pap test, colposcopy and HPV DNA test. The Pap test is a screening
treatment of cervical cancer, in which the presence of precancerous or
the cancer cells are identified on the cervix. Colposcopy is a plus
Advanced technique as a Pap test, which allows the examiner to take
Abnormal cervical tissue of the cervix.

Advent of vaccines

The global market for anti-HPV drugs has made significant progress in terms of
prevention of diseases caused by HPV. This is mainly due to the
the growing research on the development of highly advanced vaccines with a longer
half life. It has been proven that vaccines are very effective against
prevention of various viruses causing diseases and very effective
towards the prevention of various indications caused by HPV.

Vaccine multiple dose schedules

Despite the availability of vaccines for the prevention of indications
caused by HPV, the market is facing a challenge by their recurring doses.
As vaccines currently approved for HPV are developed for
administered by invasive methods such as the subcutaneous route, the
the need for multiple doses affects the patient's adherence to
completion of the dosing cycle.

Key players

• Allergan

• Health Bausch

• GlaxoSmithKline PLC

• Lee's Pharmaceutical Holdings Limited

• Merck Sharp & Dohme Corp.

Topics covered

PART 01: SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem

• Market characteristics

• Analysis of market segmentation

PART 04: MARKET CALIBRATION

• Market definition

• Sizing of the 2018 market

• Market Size and Forecast 2018-2023

PART 05: ANALYSIS FIVE STRENGTHS

• The bargaining power of buyers

• Bargaining power of suppliers

• The threat of new participants

• The threat of substitutes

• Threat of rivalry

PART 06: MARKET SEGMENTATION BY AR

• Comparison by RoA

• Parenteral – Market Size and Forecast 2018-2023

• Topic – Market Size and Forecast 2018-2023

• Market opportunity by RoA

PART 07: CLIENT LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic comparison

• North America – Market Size and Forecast for 2018-2023

• Europe – Market Size and Forecast 2018-2023

• Asia – Market Size and Forecast 2018-2023

• ROW – Market Size and Forecast 2018-2023

• Main leading countries

• Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: LANDSCAPE OF THE SELLER

• Overall view

• Disturbance of the landscape

• Competitive scenario

PART 12: ANALYSIS OF SELLER

• The covered sellers

• Vendor clbadification

• Positioning of sellers on the market

• Allergan

• Health Bausch

• GlaxoSmithKline PLC

• Lee's Pharmaceutical Holdings Limited

• Merck Sharp & Dohme Corp.

For more information on this report, visit https://www.researchandmarkets.com/research/z73lhz/global_human?w=4